Physician
Huntington Hospitalist Group INC
Huntington Hospitalist Group INC was paid $26.02M by Medicaid between Jan 2018 and Dec 2024, across 40 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 27% of everything it billed.
33Billing provider infoHUNTINGTON HOSPITALIST GROUP INC
HUNTINGTON, WV 25702
HUNTINGTON, WV 25702
33aNPI1750710166assigned 11/06/2013
33bProvider typeNephrology Physician
28Total paid$26.02M
24GClaims536,304
24DCodes billed40
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Nephrology Physician providers in West Virginia
Rank by total paid#1 of 14
Median peer was paid$89K
This provider vs. median293×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 26,911 | $1.39M | |
| 2019 | 35,431 | $1.22M | |
| 2020 | 75,947 | $3.72M | |
| 2021 | 93,403 | $4.60M | |
| 2022 | 111,502 | $5.83M | |
| 2023 | 106,357 | $5.23M | |
| 2024incomplete | 86,753 | $4.03M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 27% | 150,145 | 73,774 | $6.98M |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 25% | 144,182 | 71,391 | $6.54M |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | 18% | 66,630 | 42,766 | $4.80M |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 8.2% | 32,729 | 18,557 | $2.14M |
| G0481 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed | 6.7% | 20,060 | 9,192 | $1.75M |
| 90853 | Group psychotherapy (other than of a multiple-family group) | 2.6% | 48,578 | 24,421 | $666K |
| 99232 | Hospital visit by a doctor, follow-up daySubsequent hospital care, per day, moderate complexity | 2.1% | 19,628 | 3,389 | $553K |
| 90832 | Psychotherapy session, about 30 minutesPsychotherapy, 30 minutes with patient | 2.0% | 13,037 | 9,277 | $521K |
| G0482 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed | 1.8% | 6,207 | 3,314 | $470K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 1.3% | 3,684 | 3,381 | $343K |
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r | <1% | 3,702 | 3,134 | $236K |
| 90791 | Psychiatric diagnostic evaluationPsychiatric diagnostic evaluation | <1% | 2,283 | 2,116 | $221K |
28 more codes
| 82075 | <1% | 3,651 | $113K | |
| 90837 | Psychotherapy session, about an hour | <1% | 1,088 | $93K |
| 90834 | Psychotherapy session, about 45 minutes | <1% | 1,494 | $87K |
| 80305 | <1% | 7,060 | $70K | |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 918 | $55K |
| H0038 | Self-help/peer services, per 15 minutes | <1% | 659 | $53K |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 1,079 | $45K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 1,075 | $39K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 1,110 | $33K |
| 99223 | Prolong inpt eval add15 m | <1% | 456 | $29K |
| 99205 | Prolong outpt/office vis | <1% | 267 | $24K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 1,804 | $23K |
| 90962 | <1% | 541 | $21K | |
| 99406 | <1% | 801 | $19K | |
| 90961 | <1% | 238 | $19K | |
| 80306 | <1% | 920 | $12K | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 161 | $12K |
| 81025 | <1% | 800 | $11K | |
| 90960 | End-stage renal disease related services monthly, for patients 20 years and older, with 4 or more face-to-face visits | <1% | 125 | $11K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 268 | $11K |
| 97151 | <1% | 378 | $5K | |
| H0032 | Mental health service plan development by non-physician | <1% | 125 | $4K |
| 86328 | <1% | 32 | $2K | |
| 99236 | Prolong inpt eval add15 m | <1% | 19 | $2K |
| 99222 | Initial hospital care, per day, moderate complexity | <1% | 35 | $1K |
| 36415 | Collection of venous blood by venipuncture | <1% | 278 | $649.29 |
| 99239 | Hospital discharge day management, more than 30 minutes | <1% | 13 | $315.64 |
| 90935 | Hemodialysis procedure with single evaluation by a physician | <1% | 44 | $105.40 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialARORA, ROBIN (PRESIDENT)
| Provider | Location | Paid |
|---|---|---|
| Huntington Hospitalist Group INC | Huntington, WV | $2.50M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.